UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Dan Savage, MD

Title(s)Assistant Professor, Dean's Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yale-New Haven Hospital, New Haven, CTMD06/2016Emergency Medicine
    Amherst College, Amherst, MABA06/2006Chemistry
    Collapse Awards and Honors
    UCSF-Fresno, Department of Emergency Medicine2018Faculty Teacher of the Year
    American College of Emergency Medicine2015ACEP Resident Paper of the Year
    Amherst College2006Dr. Everett H. Pryde '39 Research Award

    Collapse Overview 
    Collapse Overview
    Dan Savage, M.D., is board certified in Emergency Medicine. He completed his medical degree at the David Geffen School of Medicine at the University of California at Los Angeles. His residency in Emergency Medicine was completed at Yale-New Haven Hospital, where he earned the position of Chief Resident.

    He is currently one of the EPIC physician builders and clinical informaticians for UCSF-Fresno and Community Medical Centers.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zupon A, Rothenberg C, Couturier K, Tan TX, Siddiqui G, James M, Savage D, Melnick ER, Venkatesh AK. An appraisal of emergency medicine clinical practice guidelines: Do we agree? Int J Clin Pract. 2019 Feb; 73(2):e13289. PMID: 30372798.
      View in: PubMed
    2. Venkatesh AK, Savage D, Sandefur B, Bernard KR, Rothenberg C, Schuur JD. Systematic review of emergency medicine clinical practice guidelines: Implications for research and policy. PLoS One. 2017; 12(6):e0178456. PMID: 28628660.
      View in: PubMed
    3. Schriger DL, Savage DF, Altman DG. Presentation of continuous outcomes in randomised trials: an observational study. BMJ. 2012 Dec 18; 345:e8486. PMID: 23249670.
      View in: PubMed
    4. Close J, Heidebrecht R, Hendrix J, Li C, Munoz B, Surdi L, Kattar S, Tempest P, Moses P, Geng X, Hughes B, Smotrov N, Moxham C, Chapnick J, Kariv I, Nikov G, Burke JE, Deshmukh S, Jeliazkova-Mecheva V, Leach JK, Diaz D, Xu L, Yang Z, Kwei G, Moy L, Shah S, Tanga F, Kenefic C, Savage D, Shearman M, Ball RG, McNevin MJ, Markarewicz A, Miller T. Lead optimization of 4,4-biaryl piperidine amides as ?-secretase inhibitors. Bioorg Med Chem Lett. 2012 May 01; 22(9):3203-7. PMID: 22483609.
      View in: PubMed
    5. Fischer C, Zultanski SL, Zhou H, Methot JL, Brown WC, Mampreian DM, Schell AJ, Shah S, Nuthall H, Hughes BL, Smotrov N, Kenific CM, Cruz JC, Walker D, Bouthillette M, Nikov GN, Savage DF, Jeliazkova-Mecheva VV, Diaz D, Szewczak AA, Bays N, Middleton RE, Munoz B, Shearman MS. Triazoles as ?-secretase modulators. Bioorg Med Chem Lett. 2011 Jul 01; 21(13):4083-7. PMID: 21616665.
      View in: PubMed
    6. Savage DF, de Crécy-Lagard V, Bishop AC. Molecular determinants of dihydrouridine synthase activity. FEBS Lett. 2006 Oct 02; 580(22):5198-202. PMID: 16962594.
      View in: PubMed